General Information of the Compound
Compound ID |
CP0210008
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3,4',5-trihydroxybibenzyl
Show/Hide
|
||||||||||||||||||
Synonyms |
1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethyl)-
3,4'',5-trihydroxybibenzyl
3,4',5-Trihydroxybibenzyl
3,5,4'-trihydroxybibenzyl
3ftu
5-(4-hydroxyphenethyl)benzene-1,3-diol
5-[2-(4-hydroxyphenyl)ethyl]-1,3-Benzenediol
5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol
58436-28-5
AC1L4HRG
AC1Q79W7
AKOS030555676
BDBM50085531
C10255
CHEBI:4582
CHEMBL111234
CTK5A8302
Dihydro-Resveratrol
Dihydroresveratol
Dihydroresveratrol
LMPK13090035
MolPort-035-706-156
NSC723534
RE2
SCHEMBL716856
ZINC899123
a, b-Dihydroresveratrol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H14O3
|
||||||||||||||||||
Molecular Weight |
230.263
|
||||||||||||||||||
Canonical SMILES |
Oc1ccc(CCc2cc(O)cc(O)c2)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H14O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h3-9,15-17H,1-2H2
Show/Hide
|
||||||||||||||||||
InChIKey |
HITJFUSPLYBJPE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
58436-28-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound